| ||||||||||||||
|
|
|||||||||||||

*Pain Clinic, General Hospital Klagenfurt, Klagenfurt, Austria; and
University of Erlangen Pain Clinic, Erlangen, Germany
Address correspondence and reprint requests to Rudolf Likar, MD, Associate Professor, Head of the Interdisciplinary Pain Clinic, General Hospital Klagenfurt, St. Veither Strasse 47, 9026 Klagenfurt, Austria. Address e-mail to r.likar{at}aon.at.
The use of opioids for treating neuropathic pain is controversial, and some studies have indicated that neuropathic pain may be relatively insensitive to typical µ-opioid analgesics such as morphine. However, it is becoming clear that different opioids produce analgesia by affecting different pain pathways. We present two cases of neuropathic pain and two cases of nociceptive pain with a significant neuropathic component that were treated with transdermal buprenorphine. In each case, sufficient pain relief was obtained and no problems were encountered in switching from prior analgesic therapy with larger doses of other opioids.
This article has been cited by other articles:
![]() |
R. Sittl Transdermal buprenorphine in cancer pain and palliative care Palliative Medicine, January 1, 2006; 20(8_suppl): 25 - 30. [Abstract] [PDF] |
||||
|